Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1995-01-13
2000-03-21
Campbell, Bruce R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
424484, 424486, 424497, 424450, 4353201, 435455, 435458, 536 231, A61K 4800
Patent
active
060402954
ABSTRACT:
Compositions and methods for administering nucleic acid compositions in vitro to cells in culture or in vivo to an organism whereby the uptake of nucleic acids is enhanced are provided. Various compositions, including thermo-reversible gels, are utilized to increase the viscosity of an administered nucleic acid formulation, thereby prolonging the localized bioavailability of the administered nucleic acid.
REFERENCES:
patent: 5512435 (1996-04-01), Stone et al.
patent: 5531925 (1996-07-01), Landh et al.
patent: 5573934 (1996-11-01), Hubbell et al.
patent: 5578325 (1996-11-01), Domb et al.
patent: 5580575 (1996-12-01), Unger et al.
patent: 5583034 (1996-12-01), Green et al.
patent: 5591721 (1997-01-01), Agrawal et al.
patent: 5770580 (1998-06-01), Ledley et al.
Mumper et al.Pharmaceutical Res., vol. 13, 5, pp. 701-709, 1996.
Kabanov et al., Biopolymers, 1991, 31/12, 1437-1443.
Monsigny et al., Ad. Drug Delivery Reviews, 14:1-24, 1994.
Ledley, Hum. Gene. Ther., 6: 1129-1144, 1995.
Kuo et al., Critical Reviews in Eukaryotic Expression 6, 1: 59-73, 1996.
Salzman et al., Critical Reviews in Eukaryotic Gene Expression, vol. 6, 1, pp. 59-73, 1996.
Monsigny et al., Advanced Drug Delivery Reviews, vol. 14, pp. 1-24, 1994.
Petrak, Pharmaceutical Particulate Carriers, 1993, pp. 275-293.
Hung et al., Gene Therapy, vol. 1, 1: pp. 64-69, 1994.
Ledley (1995) Human Gene Therapy 6: 1129-1144.
Papisov (1995) Adv. Drug Del. Rev. 16: 127-139.
Ewel et al. (1992) Cancer Research 52: 3005-3010.
Biswas et al. (1994) Journal of Biotechnology 32: 1-10.
Szoka et al. (1993) Bioconjugate Chem. 4, 372-379.
Duncan et al. (1992) Anti Cancer Drugs, 3: 175-210.
Park et al. (1993) Advanced Drug Delivery Reviews, 11: 59-84.
Bennett et al., "Inhibition of Vascular Smooth Muscle Cell Proliferation in Vitro and in Vivo by c-myc Antisense Oligodeoxynucleotides," J. Clin. Invest. 93(2):820-828 (1940).
Caso et al., "Transfection in Micromonospora spp.," Applied and Environmental Microbiology 53(10):2544-2547 (1987).
Chemla et al., "Effects of Antisense Oligonucleotides on Myointimale Hyperplasia in a Model of Abdominal Aortic Trauma in the Rat," Archives des Maladies Due Coeur Et Des Vaisseaux 88(3):381-389 (1995).
Curiel et al., "High-Efficiency Gene Transfer Mediated by Adenovirus Coupled to DNA-Polylysine Complexes," Human Gene Therapy 3:147-154 (1992).
"Reporter System Using Chloramphenicol Acetyltransferase," in Current Protocols in Molecular Biology, Supplement 29, Chapter 9, Unit 9.6A, pp. 9.6.5-9.6.6 (1993).
Davis et al., "Direct Gene Transfer into Skeletal Muscle In Vivo: Factors Affecting Efficiency of Transfer and Stability of Expression," Human Gene Therapy 4:151-159 (1993).
Edelman et al., "c-myc in Vasculoproliferative Disease," Circulation Research 76(2):176-182 (1995).
Felgner et al., "Lipofection: A Highly Efficient, Lipid-mediated DNA-transfection Procedure," Proc. Natl. Acad. Sci. USA 84:7413-7417 (1987).
Fraley et al., "Introduction of Liposome Encapsulated SV40 DNA into Cells," J. Biol. Chem. 225(21):10431-10435 (1980).
Fulton et al., "Luminescent Reporter Gene Assays for Luciferase and .mu.-Galactosidase Using a Liquid Scintillation Counter," BioTechniques 14(5):762-763 (1993).
Jain and Magrath, "A Chemiluminescent Assays for Quantitation of .mu.Galactosidase in the Femtogram Range: Application of Quantitation of .mu.-Galactosidase in lacZ-Transfected Cells," Analytical Biochemistry 199:119-124 (1991).
Klebe et al., "Uptake by Cells of Nucleic Acids Promoted by Compounds Sharing the Pleiotropic Effects of Poly(Ethylene Glycol)," Teratogenesis, Carcinogenesis and Mutagenesis 6(3):245-250 (1986).
March et al., "Facilitation of Adenoviral Gene Delivery by Poloxamer 407," Proceed. Intern. Symp. Control. Rel. Bioact. Mater. 21:348 (1994).
Mumper et al., "Interactive Polymeric Gene Delivery Systems for Enhanced Muscle Expression," Pharmaceutical Research 12(9):S80 at abstract 2005 (1995).
Nguyen et al., "Firefly Luciferase Luminescence Assays Using Scintillation Counters for Quantitation in Transfected Mammalian Cells," Analytical Biochemistry 171:404-408 (1988).
Shaper et al., "Male Germ Cell Expression of Murine .mu.4-Galactosylatransferase: A 796-base pair genomic region containing two cAMP-responsive elements (CRE)-like elements, mediates expression in transgenic mice," J. Biol. Chem. 269:25165-25171 (1994).
Uglea and Dumitru-Medvichi, "Ch. 15--Medical Applications of Synthetic Oligomers," in Polymeric Biomaterials, edited by Severian Dumitriu, Marcel Dekker, Inc., New York, pp. 725-747 (1994).
U.S. Application No. 07/913,669, filed Jul. 14, 1992.
Wagner et al., "Transferrin-polycation Conjugates as Carriers for DNA Uptake Into Cells," Proc. Natl. Acad. Sci. USA 87:3410-3414 (1990).
Weith et al., "Synthesis of Cellulose Derivatives Containing the Dihydropxyboryl Group and a Study of Their Capacity to Form Specific Complexes with Sugars and Nucleic Acid Components," Biochemistry 9(22):4396-4401 (1970).
Young et al., "Selective Inactivation of Eukaryotic .mu.-Galactosidase in Assays for Inhibitors of HIV-1 TAT Using Bacterial .mu.-Galactosidases as a Reporter Enzyme," Analytical Biochemistry 215:24-30 (1993).
Mumper Russell J.
Rolland Alain
Campbell Bruce R.
Genemedicine, Inc.
Nguyen Dave Trong
LandOfFree
Formulated nucleic acid compositions and methods of administerin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Formulated nucleic acid compositions and methods of administerin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Formulated nucleic acid compositions and methods of administerin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-730458